TABLE 2.
Diversity of mutants and their biocide and antibiotic susceptibility
Species and biocide phenotypea | Preconditioning agentb | Biocide MIC (mg/liter) |
Antibiotic MIC (mg/liter)c |
Mutant designationd | No. of CFU by platee | No. of mutants | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TRI | BKC | CHX | AMP | CAZ | CIP | ERY | GEN | CLO | TET | |||||
E. coli | ||||||||||||||
Parental strain HEC30 | 0.06 | 16 | 8 | ≥256 | 0.25 | 0.023 | 16 | 1–1.5 | 6 | 3 | ||||
TRIr | TRI | 4 | 16 | 2 | ≥256 | 0.13 | 0.032 | 16 | 0.75 | 3 | 3 | Ec_TRI/TRI2 | 2 | 3 |
CIP | 1 | 32 | 8 | ≥256 | 0.75 | 0.75 | 16 | 1 | 12 | 0.75 | Ec_CIP/CIP | 7 | ||
BKC | 0.25 | 16 | 8 | ≥256 | 0.5 | 0.032 | 16 | 1.5 | 4–12 | 3 | Ec_BKC/BKC2 | 1 | ||
TRIr CHXs | NE | 1 | 16 | 4 | ≥256 | 0.38 | 0.023 | 16 | 1–1.5 | 6 | 2 | Ec_NE/TRI1 | UC | 1 |
K. pneumoniae | ||||||||||||||
Parental strain 39.11 | 0.5 | 16 | 32 | 32 | 0.38 | 0.047 | 16 | 1 | 2 | 3 | ||||
TRIr | AMP | 2 | 32 | 64 | 64 | 0.75 | 0.094 | 16 | 1 | 128 | 4 | Kpn_AMP/TRI2 | 7 | 16 |
NE | 2 | 32 | 64 | 128 | 0.5 | 0.5 | 16 | 1 | >256 | 12 | Kpn_NE/CIP | 126 | ||
TRI | 2 | 32 | 64 | ≥256 | 0.5 | 0.5 | 16 | 1.5 | >256 | 8 | Kpn_TRI/CIP | 177 | ||
CHX | 2 | 32 | 64 | ≥256 | 0.38 | 0.38 | 32 | 0.75 | >256 | 8 | Kpn_CHX/CIP | 59 | ||
BKC | 2 | 32 | 64 | ≥256 | 1 | 0.38 | 96 | 0.75 | 64 | >128 | Kpn_BKC/CIP | 53 | ||
SHC | 2 | 32 | 64 | 128–192 | 0.75 | 0.5 | 32–48 | 1.5 | >256 | 16–24 | Kpn_SHC/CIP | 31 | ||
NE | 2 | 32 | 32 | 32 | 0.5 | 0.38 | 16 | 1 | >256 | 4 | Kpn_NE/TRI1 | UC | ||
TRI | 2 | 32 | 32 | 64 | 0.5 | 0.38 | 12 | 1 | 128 | 6 | Kpn_TRI/TRI2 | 272 | ||
BKC | 2 | 32 | 32 | 48 | 0.5 | 0.38 | 12 | 1 | 128 | 4 | Kpn_BKC/TRI2 | 12 | ||
CHX | 2 | 32 | 32 | 32 | 0.5 | 0.5 | 16 | 1 | >256 | 4 | Kpn_CHX/TRI2 | 6 | ||
CIP | 2 | 32 | 32 | 32 | 0.38 | 0.5 | 32 | 1 | >256 | 24–32 | Kpn_CIP/TRI2 | 20 | ||
TRI | 2 | 32 | 32 | ≥256 | 0.38 | 0.5 | 16 | 0.5 | >256 | 16–24 | Kpn_TRI/BKC1 | UC | ||
BKC | 2 | 32 | 32 | ≥256 | 1.5 | 0.38 | 16 | 0.5 | 192 | 32 | Kpn_BKC/BKC1 | UC | ||
CIP | 2 | 32 | 32 | ≥256 | 1.5 | 0.75 | >256 | 0.19 | 96 | 12 | Kpn_CIP/BKC2 | 11 | ||
AMP | 2 | 32 | 32 | ≥256 | 0.5 | 0.5 | 16 | 0.5 | >256 | 8 | Kpn_AMP/CIP | 152 | ||
CIP | 2 | 32 | 32 | 192 | 0.5 | 0.38 | 16 | 1 | >256 | 12 | Kpn_NE/CIP | 126 | ||
TRIhs | NE | 0.12 | 8 | 32 | 48 | 0.25 | 0.094 | 16 | 1.5 | 3 | 2 | Kpn_NE/CHX2 | 3 | 2 |
CIP | 0.12 | 16 | 16 | 32 | 0.25–0.38 | 0.094 | 16 | 1 | 4 | 1.5 | Kpn_CIP/CHX2 | UC |
TRI, triclosan; CHX, chlorhexidine.
CIP, ciprofloxacin; BKC, benzalkonium chloride; NE, no exposure; AMP, ampicillin; SHC, sodium hypochlorite.
CAZ, ceftazidime; ERY, erythromycin; GEN, gentamicin; CLO, chloramphenicol; TET, tetracycline.
When the selecting agent was TRI, the numbers in the nomenclature of mutants refer to the concentrations of the compounds in the plates as follows: 1 = 1 mg/liter and 2 = 1.5 mg/liter. When the selecting agent was CHX, the concentration in the plate was as follows: 1 = 64 mg/liter or 2 = 128 mg/liter. In the case of BKC, the numbers 1 to 3 refer to the concentrations in plates as follows: 1 = 32 mg/liter, 2 = 64 mg/liter, and 3 = 128 mg/liter. The concentration of CIP was 0.12 mg/liter in all plates.
UC, uncountable.